Result [ftcn]
Primary Outcome Measure [inpr]
Clinical Events [idcn]
Asymptomatic [fndg]
Carotid artery [bpoc]
progression [patf]
Study [mnob]
Proven [qlco]
To [qlco]
More [ftcn]
effective [qlco]
Reducing [qlco]
Levels [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
To [qlco]
Better [qlco]
Lipid [lipd]
lowering [spco]
Compound [qlco]
Most [qnco]
Trial [resa]
Evaluate [ftcn]
effects [qlco]
New Agents [clas]
progression [patf]
Atherosclerosis [dsyn]
Not [ftcn]
included [ftcn]
Individual [popg]
Asymptomatic [fndg]
Cardiovascular disease [dsyn]
Low density lipoprotein cholesterol level [lbpr]
limits [ftcn]
Established [qlco]
national [inpr]
Cholesterol [bacs, strd]
educational program [edac]
Initial [tmco]
treatment [ftcn]
Asymptomatic [fndg]
Carotid artery [bpoc]
progression [patf]
Study [mnob]
tested [inpr]
Effect [qlco]
Hydroxy [inch]
Coenzyme A [bacs, nnon]
Reductase [aapp, enzy]
Inhibitor [qlco]
Lovastatin [orch, phsu]
Early [tmco]
Stage [tmco]
Carotid Atherosclerosis [dsyn]
Detected [fndg]
Mode [ftcn]
Ultrasonography [diap]
Asymptomatic [fndg]
Men [popg]
Women [popg]
Age [orga]
Low density lipoprotein cholesterol level [lbpr]
percentiles [qnco]
participants [popg]
randomized [resa]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Design [acty]
Study [mnob]
Received [qlco]
Lovastatin [orch, phsu]
mg day [qnco]
Lovastatin [orch, phsu]
placebo [topp]
Warfarin [hops, orch, phsu]
mg% [qnco]
Warfarin [hops, orch, phsu]
placebo [topp]
progression [patf]
Mean [qnco]
Maximum [qnco]
Intima [tisu]
Medial [spco]
Thickness [qlco]
Walls [mnob]
Carotid Arteries [bpoc]
Represent [acty]
Primary [qlco]
Outcome [ftcn]
Lovastatin [orch, phsu]
treatment [ftcn]
Associated [qlco]
reduction [npop]
progression [patf]
Mean [qnco]
Maximum [qnco]
Intima [tisu]
Medial [spco]
Thickness [qlco]
P NOS [aapp, imft]
Levels [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Reduced [qlco]
mg dl [qnco]
MMOLE [qnco]
liter [qnco]
Lovastatin [orch, phsu]
Group [idcn]
months [tmco]
P NOS [aapp, imft]
Stable [qlco]
Follow-up [fndg]
Levels [qlco]
Unchanged [fndg]
Lovastatin [orch, phsu]
placebo [topp]
Group [idcn]
Incidence [qnco]
Major [qlco]
cardiovascular events [fndg]
Patients [podg]
Lovastatin [orch, phsu]
Group [idcn]
Compared [acty]
Patients [podg]
Lovastatin [orch, phsu]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Mortality [qnco]
Group [idcn]
Note [clna]
P NOS [aapp, imft]
Multivariate Analyses [qnco]
Regression [patf]
Suggest [idcn]
Primary [qlco]
Outcome [ftcn]
Benefit [qnco]
Patients [podg]
hypertensive [fndg]
national [inpr]
Cholesterol [bacs, strd]
Education [edac]
Program [cnce]
Diet [food]
Women [popg]
Using [ftcn]
Hormone replacement therapy [topp]
Asymptomatic [fndg]
Carotid artery [bpoc]
progression [patf]
Study [mnob]
Men [popg]
Women [popg]
Moderately [qlco]
Elevated [qlco]
Levels [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
experience [menp]
Reversal [ftcn]
Early [tmco]
Stage [tmco]
Carotid [bpoc]
Intima [tisu]
Medial [spco]
Thickness [qlco]
progression [patf]
Received [qlco]
Lovastatin [orch, phsu]
reductions [npop]
Incidence [qnco]
Major [qlco]
cardiovascular events [fndg]
Mortality [qnco]
Associated [qlco]
Hydroxy [inch]
Coenzyme A [bacs, nnon]
Reductase [aapp, enzy]
Inhibitor [qlco]
therapy [ftcn]
confirmed [qlco]
Large [qnco]
Secondary Prevention [topp]
Trial [resa]
